Fmr LLC Harvard Bioscience Inc Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Fmr LLC holds 72,274 shares of HBIO stock, worth $29,632. This represents 0.0% of its overall portfolio holdings.

Number of Shares

72,274

Previous 23,028 213.85%

Holding current value

$29,632

Previous $13,000 138.46%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$0.28 - $0.69 $13,788 - $33,979	49,246 Added 213.85%	72,274 $31,000
Q1 2025 May 12, 2025	BUY	$0.57 - $2.19 $10,213 - $39,242	17,919 Added 350.73%	23,028 $13,000
Q4 2024 Feb 13, 2025	BUY	$2.02 - $2.82 $1,626 - $2,270	805 Added 18.7%	5,109 $10,000
Q3 2024 Nov 13, 2024	BUY	$2.64 - $3.54 $142 - $191	54 Added 1.27%	4,304 $11,000
Q2 2024 Aug 13, 2024	BUY	$2.77 - $4.63 $11,609 - $19,404	4,191 Added 7103.39%	4,250 $12,000
Q1 2024 May 13, 2024	SELL	$4.02 - $5.39 $828 - $1,110	-206 Reduced 77.74%	59 $0
Q4 2023 Feb 13, 2024	BUY	$4.0 - $5.49 $868 - $1,191	217 Added 452.08%	265 $1,000
Q3 2023 Nov 13, 2023	BUY	$4.0 - $5.82 $32 - $46	8 Added 20.0%	48 $0
Q2 2023 Aug 11, 2023	BUY	$4.19 - $6.16 $167 - $246	40 New	40 $0
Q2 2022 Aug 12, 2022	SELL	$3.28 - $6.42 $3,306 - $6,471	-1,008 Reduced 73.31%	367 $1,000
Q1 2022 May 13, 2022	BUY	$5.16 - $7.14 $5,067 - $7,011	982 Added 249.87%	1,375 $8,000
Q4 2021 Feb 14, 2022	BUY	$6.37 - $8.18 $2,503 - $3,214	393 New	393 $3,000

Others Institutions Holding HBIO

# of Institutions

Shares Held

22.6M

Call Options Held

101K

Put Options Held

22K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $17.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account